Accessibility Menu
BICO Group logo

BICO Group

(OTC) BCCOY

Current Price$0.37
Market Cap$101.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-98%
5 YearN/A
1 Year-54%
1 Month-26%
BICO Group last closing stock price
MetricPriceDate
Last closeUSD 0.372026-07-15
BICO Group stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-26.24%USD 0.502026-06-03
1 month-26.24%USD 0.502026-06-03
3 month-37.05%USD 0.592026-04-09
Year to date-33.61%USD 0.562025-12-29
1 year-53.9%USD 0.802025-07-10
3 year-52.2%USD 0.772023-06-30
Since inception-97.51%USD 14.802021-09-29

BICO Group Financials at a Glance

Market Cap

$101.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SEK 1.48B

Net Income (TTM)

-SEK 976.52M

EPS (TTM)

-$0.37

P/E Ratio

-1.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.37

Volume

200

Open

$0.37

Previous Close

$0.37

Daily Range

$0.37 - $0.37

52-Week Range

$0.35 - $0.80

Estimated Earnings Date

Apr 27, 2026

BCCOY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BICO Group

BICO Group AB (publ) is a leading bio-convergence company based in Gothenburg, Sweden, specializing in advanced bioprinting and bioautomation technologies. Founded in 2016, the company operates globally, providing innovative solutions to the medical, pharmaceutical, and biotechnology sectors.

Products and Services
  • 3D bioprinters and hybrid microscopes for laboratory applications
  • Precision dispensing and biosensor technologies for industrial clients
  • Specialized services in 3D cell culture and digital pathology
Growth Outlook
  • Revenue increased to SEK 329.9 million in Q1 2026
  • Gross profit margin improved to 54.1% in Q1 2026
  • Expansion into North America and Asia enhances market reach
Financial Highlights
  • Trailing twelve-month revenue of SEK 1.5 billion
  • Operating income margin at -27.6% in Q1 2026
  • Cash and cash equivalents of SEK 740.2 million as of Q1 2026
BICO Group AB operates through two main divisions: Laboratory Solutions and Bioautomation. The Laboratory Solutions segment focuses on providing sophisticated scientific equipment and consumables, while the Bioautomation segment delivers advanced robotics and automation solutions tailored for the medical and diagnostic sectors. The company has shown promising growth, with a significant increase in revenue and an improved gross profit margin in the most recent quarter. The expansion into new markets is expected to further enhance growth prospects. Financially, the company maintains a strong cash position, which supports ongoing investments in research and development.
AI Generated • Jun 21, 2026

Industry

Life Sciences Tools and Services

Sector

Health Care

Employees

602

CEO

Maria Ada Eufemia Forss, MBA

Website

bico.com

Headquarters

Gothenburg, VG 413 46, SE

BCCOY Financials

Key Financial Metrics (TTM)

Gross Margin

44.96%

Operating Margin

-16.32%

Net Income Margin

-66.09%

Return on Equity

-51.81%

Return on Capital

-7.28%

Return on Assets

-33.20%

Earnings Yield

-100.00%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$101.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

276.30M

Volume

200

Avg. Volume

158.887

Financials (TTM)

Gross Profit

SEK 664.89M

Operating Income

-SEK 242.85M

EBITDA

-SEK 1.05B

Operating Cash Flow

SEK 38.75M

Capital Expenditure

-SEK 17.30M

Free Cash Flow

SEK 21.45M

Cash & ST Invst.

SEK 740.18M

Total Debt

SEK 690.60M

BICO Group Performance Analysis

BICO Group annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31SEK 209,567,42543.1%
20232023-12-31SEK 189,375,529-9.6%
20242024-12-31SEK 163,363,659-13.7%
20252025-12-31SEK 152,658,541-6.6%
BICO Group sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30-16.6%
Q32025-09-3017.6%
Q42025-12-3116.0%
Q12026-03-31-25.4%
BICO Group annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31SEK -0.30180.7%
20232023-12-31SEK -0.3929.1%
20242024-12-31SEK -0.00-99.5%
20252025-12-31SEK -0.3921750.0%
BICO Group sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3091.9%
Q32025-09-30-3096.3%
Q42025-12-3190.5%
Q12026-03-31-124.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

SEK 329.90M

-15.1%

Gross Profit

SEK 178.60M

-5.9%

Gross Margin

54.14%

N/A

Market Cap

$101.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$146.62K

N/A

Employees

695

N/A

Net Income

-SEK 131.30M

+43.9%

EBITDA

-SEK 33.20M

-12.2%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

SEK 740.18M

+986.5%

Total Debt

SEK 690.60M

-51.0%

Accounts Receivable

SEK 264.70M

-5.9%

Inventory

SEK 198.00M

-19.9%

Long Term Debt

SEK 626.70M

+142.4%

Short Term Debt

SEK 63.90M

-94.4%

Return on Assets

-33.20%

N/A

Return on Invested Capital

-10.08%

N/A

Free Cash Flow

SEK 42.30M

-39.9%

Operating Cash Flow

SEK 47.30M

-38.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MLLCFMolecular Partners AG
$3.80+0.00%
NDTPNDT Pharmaceuticals Inc.
$0.30-24.25%
YOURFYourWay Cannabis Brands Inc.
$0.00+0.00%
WLDFFWildflower Brands Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$15.60-0.00%
ATAIAtaiBeckley
$7.15+0.33%
NOKNokia
$10.38-0.08%
ONDSOndas
$6.65-0.06%

Questions About BCCOY

What is the current price of BICO Group?

BICO Group is trading at $0.37 per share.

What is the 52-week range for BICO Group?

Over the past 52 weeks, BICO Group has traded between $0.35 and $0.80.

How much debt does BICO Group have?

As of the most recent reporting period, BICO Group reported total debt of SEK 72.49M.

How much cash does BICO Group have on hand?

BICO Group reported SEK 78.13M in cash and cash equivalents in its most recent financial results.

What is BICO Group’s dividend yield?

BICO Group does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services